课题基金 / 基金详情

3TC VERSUS THE BEST OF THERAPIES IN ACTG 152

3TC VERSUS THE BEST OF THERAPIES IN ACTG 152
3TC 与 ACTG 152 中最佳疗法的对比
批准号:
6280831
负责人:
ANN PETRU
金额:
$2.39万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

ANN PETRU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study was designed to determine which drug or combination of drugs will be best for children who had less than 6 weeks of prior antiretroviral therapy. It compares the combination of AZT and a new drug, 3TC, with either ddI alone or the combination of AZT/ddI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LATE OUTCOMES FOR TREATMENT OF HIV INFECTION
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN CHILDRENPACTG 1010
ACTG P1024
ACTG P1024 EVALUATION OF THE IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINE...
海外基金